This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Yinjian Zhou: Innovator in pH-sensitive Drug Delivery Systems
Introduction
Yinjian Zhou is a prominent inventor based in Beijing, China. He has made significant contributions to the field of drug delivery systems, particularly through his innovative work on pH-sensitive compositions. His research focuses on enhancing the efficacy of cancer treatments by utilizing advanced polymer conjugates.
Latest Patents
Yinjian Zhou holds a patent for "PH-sensitive compositions for delivery of beta lapachone and methods of use." This patent discloses compounds that comprise a polymer conjugated with a pH-sensitive prodrug of beta-lapachone. The compound is capable of forming a micelle, and the pH-sensitive prodrug includes a pH-sensitive linker selected from aryl imine and aliphatic imine. The patent also outlines methods for treating cancer using these micelles, showcasing Zhou's commitment to improving therapeutic strategies.
Career Highlights
Yinjian Zhou is affiliated with the University of Texas System, where he continues to advance his research in drug delivery technologies. His work has garnered attention for its potential to revolutionize cancer treatment methodologies. With a focus on innovative solutions, Zhou has established himself as a key figure in the field.
Collaborations
Yinjian Zhou has collaborated with notable colleagues, including Erik Bey and David A Boothman. These partnerships have further enriched his research endeavors and contributed to the development of effective cancer therapies.
Conclusion
Yinjian Zhou's contributions to pH-sensitive drug delivery systems exemplify his dedication to advancing medical science. His innovative patent and collaborative efforts position him as a leading inventor in the field of cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
